e-Drug3D 936 |
cas 142217-69-4 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
ATC code |
PK parameters F 100 PERCENT Solubility SLIGHTLY SOLUBLE IN WATER |
Target TARGET HBV REVERSE TRANSCRIPTASE |
DrugCentral Protein P UNIPROT Q9IF40 P |
Download SDF file | 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one Formula: Calculated chemical properties: MW 277.29 NB_atoms 20 XLogP -0.83 PSA 121.244 NB_HD 5 NB_HA 8 fsp3 0.42 Lipinski(0=no;1=yes) 1 |
FDA NDA 021797 (label) INN (ENTECAVIR) BARACLUDE (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 2005 NDA 021798 (label) INN (ENTECAVIR) BARACLUDE (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 2005 NDA 202122 (pdf not found) INN (ENTECAVIR) ENTECAVIR (TEVA PHARMS USA) APPROVAL= AP YEAR= 2014 DISCONTINUED NDA 205740 (pdf not found) INN (ENTECAVIR) ENTECAVIR (HETERO LABS LTD V) APPROVAL= AP YEAR= 2015 NDA 206217 (pdf not found) INN (ENTECAVIR) ENTECAVIR (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2015 NDA 206652 (pdf not found) INN (ENTECAVIR) ENTECAVIR (AMNEAL PHARMS) APPROVAL= AP YEAR= 2015 NDA 206294 (pdf not found) INN (ENTECAVIR) ENTECAVIR (CHARTWELL RX) APPROVAL= AP YEAR= 2016 DISCONTINUED NDA 206872 (pdf not found) INN (ENTECAVIR) ENTECAVIR (CIPLA) APPROVAL= AP YEAR= 2016 NDA 206672 (pdf not found) INN (ENTECAVIR) ENTECAVIR (CHARTWELL RX) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 206745 (pdf not found) INN (ENTECAVIR) ENTECAVIR (ZYDUS PHARMS) APPROVAL= AP YEAR= 2017 NDA 205824 (pdf not found) INN (ENTECAVIR) ENTECAVIR (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 208782 (pdf not found) INN (ENTECAVIR) ENTECAVIR (PRINSTON INC) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 208721 (pdf not found) INN (ENTECAVIR) ENTECAVIR (BRECKENRIDGE) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 206226 (pdf not found) INN (ENTECAVIR) ENTECAVIR (RISING) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 212126 (pdf not found) INN (ENTECAVIR) ENTECAVIR (BRIGHTGENE) APPROVAL= AP YEAR= 2019 NDA 212201 (pdf not found) INN (ENTECAVIR) ENTECAVIR (YAOPHARMA CO LTD) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 211978 (pdf not found) INN (ENTECAVIR) ENTECAVIR (SUNSHINE) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 212106 (pdf not found) INN (ENTECAVIR) ENTECAVIR (PHARMADAX) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 208195 (pdf not found) INN (ENTECAVIR) ENTECAVIR (YUNG SHIN PHARM) APPROVAL= AP YEAR= 2021 NDA 216857 (pdf not found) INN (ENTECAVIR) ENTECAVIR (CONBA USA) APPROVAL= AP YEAR= 2024 |
Other links: | |
e-Drug3D 1640 |
cas 336608-44-7 |
CLASS ANTIINFECTIVES |
ROUTE (list) - |
ATC code |
PK parameters t1/2 15 HOUR |
Target TARGET HBV REVERSE TRANSCRIPTASE |
DrugCentral Protein P UNIPROT Q9IF40 P |
Download SDF file | Triphosphoric acid, P-[[(1R,3S,5S)-3-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-5-hydroxy-2-methylenecyclopentyl]methyl] ester Formula: Calculated chemical properties: MW 513.19 NB_atoms 32 XLogP -3.00 PSA 252.017 NB_HD 4 NB_HA 17 fsp3 0.42 Lipinski(0=no;1=yes) 0 |
FDA - |
Other links: |